Indefinite Delivery Contract SPE2DR25D3009

The federal contract IDV award SPE2DR25D3009 is a $999,999,999 Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp as the prime contractor. The contract provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This IDC serves as a primary vehicle for DLA to efficiently procure essential pharmaceutical and medical commodities for military personnel, veterans, and other federal beneficiaries through a streamlined contracting mechanism.

The original solicitation, planned for March 2024, aims to establish multiple Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contracts with an estimated total value of $30.3 billion to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, the U.S. Coast Guard, and other government agencies. The contract will have a 30-month base period with three 30-month option periods, and awards will be made on a regional basis with the intention of having at least three different contractors across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet line items to ensure resiliency and access to vital pharmaceuticals during contingencies or natural disasters.